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ABSTRACT 
Oral Drug Delivery is considered as the holy grail of drug delivery due to its convenience which resulted in high patient com pliance. Of all the 
drug delivery systems that have been explored, oral drug delivery is the most preferred option for systemic delivery of drug via various 
pharmaceutical products of different dosage forms. The advantage of administering a single dose of drug which is released over an extended 
period of time, instead of administering numerous doses, is now a day’s area of interest for formulation scientists in the pharmaceutical 
industry. For this reason, the conventional dosage forms of drugs are rapidly being replaced by the new and the novel drug delivery systems. 
Amongst these, the controlled release dosage forms have gradually gained medical acceptance and became extremely popular in modern 
therapeutics. The aim of the present work is to isolate Aegle marmelos gum and use it as a controlled release polymer in the formulation of 
diltiazem hydrochloride controlled release tablets.  
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INTRODUCTION 
Several approaches are currently used to retain the dosage 
form in the gastro-intestinal tract. The principle of the 
controlled release tablets is simple and practically 
approached to obtain prolonged release of drug. Controlled 
release tablets design needs a strong release retarding 
polymer. Aegle marmelos gum, a novel naturally isolated 
polymer was tried as ‘release retarding’ polymer in the 
design of controlled release tablets. 
MATERIALS AND METHODS 
Materials 
1) Diltiazem Hydrochloride (Yarrow Chemicals, Mumbai) 
2) Aegle marmelos gum (Isolated in the Laboratory) 
3) Lactose (Yarrow Chemicals, Mumbai) 
4) Talc (Molychem, Mumbai) 
5) Magnesium stearate (Molychem, Mumbai) 
Isolation of Gum from Aegle Marmelos Fruits: 
The edible pulp of Aegle marmelos fruit was collected and 
soaked in double distilled water. After soaking, it was boiled 
for 5 hours in a water bath until slurry was formed. Thus 
formed slurry was cooled and refrigerated over-night so that 
most of the undissolved portion was settled out. The upper 
clear solution was decanted off and centrifuged at 500 rpm 
for 20 minutes. The supernatant was allowed to concentrate 
at 60o C on a water bath until the volume reduced to one-
third of its original volume. Solution was cooled to room 
temperature and was poured into acetone (three times the 
volume of slurry) with continuous stirring to form 
precipitate.  Thus formed precipitate was separated, washed 
repeatedly with acetone and dried under vacuum at 50oC in 
an oven. The completely dried gum was powdered and was 
passed through sieve #100, packed in a tightly closed 
container and stored in a dessicator for further usages.   
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Methods 
Preparation of Diltiazem Hydrochloride Controlled 
Release Matrix Tablets Employing 
Aegle marmelos Gum 
Oral controlled release matrix tablets each containing 90mg 
of Diltiazem hydrochloride were prepared by wet 
granulation method using different drug: gum ratios viz. 
1:0.25, 1:0.5, 1:1 and 1:1.25 for various formulations 
containing Aegle marmelos gum. The composition of 
different formulations of Diltiazem Controlled Release 
tablets is shown in Table 2. All the ingredients of the 
formulation were accurately weighed and the coherent mass 
was formed using distilled water as granulating fluid. The 
coherent mass was passed through mesh No. 12 and the 
granules obtained were air dried. The lubricants talc (2%) 
and magnesium stearate (2%) were passed through mesh 
No. 60 onto the dry granules and blended in a closed 
polyethylene bag. The tablet granules were compressed into 
tablets on an 8 – station tablet punching machine (Shakthi 
Pharmatech Pvt Ltd., Ahmedabad) to a hardness of 5 – 6 
kg/sqcm. The compressed tablets were stored in a closed 
container. 
Evaluation of Diltiazem Hydrochloride Controlled 
Release Tablets 
The prepared formulations were evaluated for the following 
parameters: 
1. Pre-compression Evaluation 
i. Angle of Repose: 
The angle of repose of granules was determined by the 
funnel method. The accurately weighed (10gms) granules 
were taken in the funnel. The granules were allowed to flow 
freely through the funnel on to the surface. The diameter of 
the granules cone was measured and angle of repose was 
calculated using the following equation: 
      
Where, θ = angle of repose, 
h = height of the cone, and 
r = radius of the cone base (1) 
ii. Bulk Density: 
Bulk density (Db) was determined by measuring the volume 
(Vb) of known weighed quantity (W) of granules using bulk 
density apparatus and can be calculated by using the 
formula: 
 
iii. Tapped Density: 
Tapped density (Dt) was determined by measuring the 
volume (Vt) of known weighed quantity (W) of granules 
after desired mechanical tapping using tapped density tester 
and can be calculated by using the formula: 
 
iv. Hausner’s Ratio: 
The Hausner’s ratio was obtained by dividing the tapped 
density by the bulk density of the granules. 
 
v. Carr’s Index: 
The Carr’s index (% compressibility) of the granules was 
calculated from the difference between the tapped and bulk 
densities divided by the tapped density and the ratio is 
expressed as a percentage (1).  
 
The results of Pre-compression Evaluation are tabulated in 
table in Table 3. 
2. Post-compression Evaluation 
i. Tablet Thickness: 
The thickness of the tablets was determined by using vernier 
caliper. Five tablets were used, and average values were 
calculated (2). 
ii. Hardness: 
Hardness indicates the ability of a tablet to withstand 
mechanical shocks while handling. The hardness of the 
tablets was determined using Monsanto hardness tester. It is 
expressed in kg/cm2. Three tablets were randomly picked 
and hardness of the tablets was determined (2). 
iii. Weight Variation: 
 
To study weight variation twenty tablets of the formulation 
were weighed using a digital balance and the test was 
performed according to the official method. The 
specification for weight variation of tablets as per USP. 
Twenty tablets were selected randomly and weighed 
individually to check for weight variation (2). 
iv. Friability: 
The friability of tablets was determined using Roche 
Friabilator. It is expressed in percentage (%). Ten tablets 
were initially weighed and transferred into friabilator. The 
friabilator was operated at 25 rpm for 4 minutes. The tablets 
were weighed again. The % friability was then calculated by: 
                
                          
             
     
% Friability of tablets less than 1% are considered 
acceptable (2). 
v. Content Uniformity: 
Five tablets were weighed individually and powdered. The 
powder equivalent to average weight of tablets was weighed 
and drug was extracted in methanol and then the methanolic 
extract was filtered and collected into 100 ml volumetric 
flasks. The solution was then made up to volume with 
methanol. After suitable dilution, the drug content was then 
determined by measuring the absorbance at 240 nm using 
Elico SL210 UV-Visible double beam spectrophotometer. 
The drug content was estimated from the standard curve of 
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Diltiazem hydrochloride. Four samples of tablet powder 
were analyzed in each case (2). 
vi. Disintegration Time: 
Disintegration time test was carried out according to USP 
specification. 6 tablets were placed in a disintegration tester 
filled with distilled water at 37±0.20C. The tablets were 
considered completely disintegrated when all the particles 
passed through the wire mesh. Disintegration times 
recorded are mean of two determinations (2). 
vii. In-vitro Dissolution Studies 
Release of Diltiazem hydrochloride from the matrix tablets 
was studied using an eight basket USP dissolution apparatus 
taking 900 mL of 0.1 N HCl (pH 1.2) solution for first 2 hrs 
and phosphate buffer (pH 7.2) for next 22 hrs. The 
dissolution media were maintained at a temperature of 37°± 
0.5°C. The speed of rotation of basket was maintained at 50 
rpm. Aliquot equal to 5 ml sample was withdrawn at specific 
time intervals and the dissolution media volume was 
complimented with fresh and equal volume of phosphate 
buffer. The samples were filtered and suitably scanned with 
appropriate dilution and amount of Diltiazem hydrochloride 
released from the tablet samples was determined 
spectrophotometrically at a wavelength of 240 nm by 
comparing with the standard calibration curve (2). 
viii. Kinetic Modelling of Drug Release 
The dissolution profiles of all the batches was fitted to 
various models like zero-order, first order, Korsmeyer and 
Peppas, and Higuchi models to ascertain the kinetic 
modeling of drug release. 
1. Zero Order Kinetics: 
Drug dissolution from dosage forms that do not disaggregate 
and release the drug slowly can be represented by the 
equation: 
Q0 - Qt = K0t  — (1) 
Rearrangement of equation (1) yields: 
Qt = Q0 + K0t   — (2) 
Where Qt is the amount of drug dissolved in time t, Q0 is the 
initial amount of drug in the solution (most times, Q0 = 0) 
and K0 is the zero order release constant expressed in units 
of concentration/time. 
To study the release kinetics, data obtained from in vitro 
drug release studies were plotted as cumulative amount of 
drug released versus time. 
2. First Order Kinetics:  
This model has also been used to describe absorption 
and/or elimination of some drugs, although it is difficult to 
conceptualize this mechanism on a theoretical basis . The 
release of the drug which followed first order kinetics can be 
expressed by the equation: 
  
  
     — (3) 
Where K is first order rate constant expressed in units of 
time-1. 
Equation (3) can be expressed as: 
Log C = log C0 - Kt / 2.303 — (4) 
Where C0 is the initial concentration of drug, k is the first 
order rate constant, and t is the time. The data obtained are 
plotted as log cumulative percentage of drug remaining vs. 
time which would yield a straight line with a slope of -
K/2.303.  
3. Higuchi Model: 
This model is based on the hypotheses that — 
(i) Initial drug concentration in the matrix is much higher 
than drug solubility. 
(ii) Drug diffusion takes place only in one dimension (edge 
effect must be negligible). 
(iii) Drug particles are much smaller than system thickness. 
(iv) Matrix swelling and dissolution are negligible. 
(v) Drug diffusivity is constant and 
(vi) Perfect sink conditions are always attained in the 
release environment.  
Accordingly, model expression is given by the equation: 
ft = Q = A √D(2C - Cs) Cs t — (5) 
Where Q is the amount of drug released in time t per unit 
area A,  
C is the drug initial concentration,  
Cs is the drug solubility in the matrix media and  
D is the diffusivity of the drug molecules (diffusion 
coefficient) in the matrix substance. 
The data obtained were plotted as cumulative percentage 
drug release versus square root of time (3). 
4. Korsmeyer-Peppas Model: 
To find out the mechanism of drug release, first 60% drug 
release data were fitted in Korsmeyer-Peppas model 
Korsmeyer et al. (1983) derived a simple relationship which 
described drug release from a polymeric system equation: 
Mt / M = Ktn — (6) 
Where Mt/M∞ is a fraction of drug released at time t, k 
is the release rate constant and n is the release exponent. 
The n value is used to characterize different release for 
cylindrical shaped matrices. 
 
Table 1: Interpretation of diffusional release mechanisms from polymeric systems 
Release Exponent (n) Drug Transport Mechanism Rate as a Function of time 
0.5 Fickian Diffusion t -0.5 
0.45 < n < 0.89 Non-Fickian Diffusion t n-1 
0.89 Case II Transport Zero order release 
Higher than 0.89 Super Case II Transport t n-1 
To study the release kinetics, data obtained from in vitro drug release studies were plotted as log cumulative percentage drug 
release versus log time (4,5). 
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Table 2: Formulae of Diltiazem Hydrochloride Controlled Release Tablets Prepared Employing Aegle marmelos Gum 
Ingredients (mg) F1 F2 F3 F4 F5 
Diltiazem hydrochloride 90 90 90 90 90 
Aegle marmelos gum 22.5 45 67.5 90 112.5 
Lactose 175.5 153 130.5 108 85.5 
Talc 6 6 6 6 6 
Magnesium stearate 6 6 6 6 6 
Total Weight of Tablet (mg) 300 300 300 300 300 
 
Table 3: Characteristics of Diltiazem Hydrochloride Granules Prepared with Different Concentrations of Aegle 
marmelos gum 
Formulation Bulk Density 
(g/cc) 
Tapped Density 
(g/cc) 
Angle of Repose 
(o) 
Carr’s Index (%) Hausner’s Ratio 
F1 0.357 ± 0.020 0.400 ± 0.143 20.44 ± 0.210 10.75 ± 0.03 1.120 ± 0.06 
F2 0.370 ± 0.121 0.434 ± 0.129 24.91 ± 0.036 14.70 ± 0.19 1.172 ± 0.123 
F3 0.384 ± 0.062 0.454 ± 0.017 27.19 ± 0.261 15.40 ± 0.05 1.183 ± 0.151 
F4 0.416 ± 0.085 0.476 ± 0.065 26.56 ± 0.091 12.66 ± 0.15 1.144 ± 0.103 
F5 0.396 ± 0.062 0.466 ± 0.089 22.32 ± 0.191 15.96 ± 0.12 1.156 ± 0.050 
 
Table 4: Physical Properties: Thickness, Hardness, Friability, Weight Variation, Drug Content of Diltiazem 
Hydrochloride Controlled Release Tablets Prepared Employing Aegle marmelos Gum 
Formulation Thickness 
(mm) 
Hardness (Kg/cm2) 
± S.D 
Friability (%) 
± S.D 
Weight Variation 
(mg) 
Drug Content 
(mg/tab)±S.D 
F1 4.65 ± 0.21 5.2 ± 0.86 0.24 ± 0.02 299.45 ± 0.26 88.45 ± 0.36 
F2 4.82 ± 0.10 5.2 ± 0.58 0.23 ± 0.04 299.61 ± 0.11 88.56 ± 0.25 
F3 4.74 ± 0.35 5.2 ± 0.64 0.23 ± 0.02 299.17 ± 0.02 89.23 ± 0.11 
F4 4.88 ± 0.26 5.3 ± 0.75 0.2 ± 0.03 300.06 ± 0.19 90.0 ± 0.16 
F5 4.91 ± 0.30 5.4 ± 0.62 0.19 ± 0.05 300.02 ± 0.06 89.97 ± 0.32 
 
 
Fig 1: Release Profiles of Diltiazem HCl Controlled Release Tablets Prepared Employing 
Aegle marmelos Gum  
 
Fig 2: Time Vs Log Cumulative Percent Drug Remaining Plots of Diltiazem HCl Controlled Release Tablets Prepared 
Employing Aegle marmelos Gum 
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Fig 3: Square Root Time Vs Cumulative Percent Drug Released Plots of Diltiazem HCl Controlled Release Tablets 
Prepared Employing Aegle marmelos Gum   
 
Fig 4: Log Time Vs Log Cumulative Percent Drug Released Plots of Diltiazem HCl Controlled Release Tablets Prepared 
Employing Aegle marmelos Gum   
 
Table 5: Correlation Coefficient (R2) Values in the Analysis of Release Data as per Zero order, First order, Higuchi and 
Peppas Equation Models 
Formulation Zero Order Model First Order Model Higuchi Model Peppas Equation 
F1 0.9733 0.7507 0.9623 0.9677 
F2 0.9798 0.9748 0.9474 0.9646 
F3 0.9791 0.8691 0.9775 0.9787 
F4 0.9625 0.9252 0.9292 0.9220 
F5 0.9976 0.7184 0.9381 0.9816 
 
Table 6: Release Characteristics of Diltiazem Hydrochloride Controlled Release Tablets Prepared Employing Aegle 
marmelos Gum 
Formulation % Release in 24 h 
± S.D 
T50  
(hr) 
Ko 
(mg/hr) 
K1   
(h-1) 
‘n’ in Peppas 
Equation 
F1 98.91 ± 0.44 3.2 11.459 0.4833 0.6233 
F2 99.89 ± 0.2 4.7 7.9338 0.1640 0.8041 
F3 96.29 ± 0.38 10.5 3.2846 0.0924 0.7657 
F4 86.66 ± 0.6 13.2 3.058 0.0835 0.5415 
F5 99.45 ± 0.22 12.0 3.6736 0.1271 0.8610 
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RESULTS AND DISCUSSION 
Aegle marmelos gum obtained after extraction from its fresh 
fruit pulp was an amorphous, free flowing powder, with 
yellow color, sweet in taste and with characteristic sweetish 
odor. Controlled release tablets each containing 90mg of 
Diltiazem hydrochloride could be prepared employing Aegle 
marmelos gum as controlled release matrix polymer and 
release retardant by wet granulation technique. 
Hardness of tablets was in range of 5.2 - 5.4 kg/sqcm. Weight 
loss in the friability test was less than 0.24 % in all the cases. 
All the matrix tablets prepared contained Diltiazem 
hydrochloride within 100 ± 5% of the labeled claim. All the 
tablets were found to be non-disintegrating in water and 
aqueous acidic (pH fluids) fluids. As such the prepared 
controlled release tablets were of good quality with regard to 
the drug content, hardness, and friability (Table 4).  
Diltiazem hydrochloride release profiles of the controlled 
release tablets are shown in Fig 1 - 4. Diltiazem 
hydrochloride release from controlled release tablets was 
spread over 24h depending on the concentration of Aegle 
marmelos gum. 
The dissolution data of tablets F1 to F5 was fitted to zero 
order, first order, Korsmeyer and Peppas and Higuchi 
models. The results of correlation coefficient (R2) were used 
to select the most appropriate model. The release profiles of 
formulations F1-F5 fitted the best to zero order model (Table 
1). Thus, it may be concluded that drug release from the 
controlled release Diltiazem hydrochloride tablets is best 
explained by zero order model. Percent drug released versus 
square root time were found to be linear. This indicates that 
the drug release from the prepared controlled release tablets 
was diffusion controlled. The release data was also analyzed 
by the Korsmeyer and Peppas equation shown below in 
order to assess the release mechanism. 
Mt /M = K tn 
Log (Mt / M) = log K + n log t 
In the above equation, Mt /M is the fractional release of the 
drug, t is the release time, ‘k’ is the constant for incorporating 
structural and geometric characteristics of the relative 
device and n is the release exponent that could be used to 
characterize the different release mechanisms as n=0.5 
(fickian diffusion), 0.5 < n < 1 non-fickian (anomalous 
transport), n = 1 (case II transport i.e., Zero order release) 
and n>1 (super class II transport). The release exponent ‘n’ 
was in range 0.5415 - 0.8610 with all the controlled release 
tablets prepared, indicating drug release from all these 
formulations was by non-fickian (anomalous) diffusion. 
CONCLUSION 
Aegle marmelos gum is an efficient release retarding polymer 
for controlled release tablets. Drug release from the 
prepared tablets was slowed over more 24h and depended 
on the composition of Aegle marmelos gum. Diltiazem 
hydrochloride release was diffusion controlled and followed 
zero order kinetics. Non-fickian diffusion was the drug 
release mechanism exhibited by the prepared Diltiazem 
hydrochloride controlled release tablets. 
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